ABSI Absci Corp
1,305
$4.47
$0.14
(3.04%)
| Watchers | 1,305 |
| 52-Wk Low | $1.11 |
| 52-Wk High | $6.72 |
| Market Cap | $521.32M |
| Volume | 619,260.00 |
| 52-Wk High | $6.72 |
| 52-Wk Low | $1.11 |
The Analyst Verdict: Absci In The Eyes Of 6 ExpertsBenzinga • 8 days ago
Latest Ratings for ABSI
DateFirmActionFromTo Feb 2022BerenbergInitiates Coverage OnBuy Nov 2021B of A SecuritiesDowngradesNeutralUnderperform Aug 2021StifelInitiates Coverage OnHold
View More...
Share to Feed
Absci Co. (NASDAQ:ABSI - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $5.61, but opened at $5.37. Absci shares last traded at $5.24, with a...
VANCOUVER, Wash. and NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...
ABSI's Q4 and Full Year 2023 Financial Results Show Continued Investment in AI-Driven Drug DiscoveryRelated Stocks: ABSI...
Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties Strengthened...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ABSI stock results show that Absci missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of...
Absci Co. (NASDAQ:ABSI Get Free Report) was the target of a large growth in short interest in February. As of February 29th, there was short interest totalling 10,620,000 shares, a growth of...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Absci (NASDAQ:ABSI Get Free Report)s stock had its buy rating reiterated by equities researchers at Truist Financial in a research note issued on Wednesday...
Latest Updates of Viva Biotech's Portfolio Companies Latest Updates of Viva Biotech's Portfolio Companies PR Newswire HONG KONG, March 6, 2024 HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the...